Uncategorized

Clinical outcome studies show cost savings and improved patient outcomes with pharmacogenetics in cardiovascular and mental health as well as in other areas including infectious disease, long term care, and adverse drug reactions Cardiovascular Antiplatelet post-MI Notarangelo et al 2018. PMID 29540324 Over 12 months, CV death/MI/stroke/major bleeding...

GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors TYDO and TELUS Ventures. Following early commercial success in Canada, this financing supports GenXys plans...

Great attendance with many opportunities to connect with clients and partners. Thank you for visiting our booth to learn more about how precision prescribing software is transforming healthcare delivery making patient-centered care front and center. Traversing innovative technologies to enable the translation of precision medicine into the clinic Precision...